Report Id: SNS/HC/1792 | June 2022 | Region: Global | 125 Pages
Telehealth and Telemedicine Market Overview:
The Telehealth and Telemedicine Market Size was valued at USD 68.8 billion in 2021, and expected to reach USD 360.5 billion by 2028, and grow at a CAGR of 26.7% over the forecast period 2022-2028.
Telehealth is at the cusp of breaking into the standard driven by combination of administrative and innovative change at the background of a quick developing medical services scene. The terms telehealth and telemedicine are frequently utilized reciprocally, however both portray the utilization of clinical data traded starting with one site then onto the next by means of electronic correspondences to further develop the patient's wellbeing status. It is additionally depicted in not many medical services circles as Virtual Medicine or VirtMed.
Telemedicine has been around for decades to finally overcome the challenges of technology, law and restitution. Recent regulatory and technological breakthroughs are driving change that leads to: 1. health reforms, representing a good foundation as millions of new lives are added creating the need for less expensive services in a much smaller environment 2. the latest telephone laws. a better option for providers with compliant laws and to improve licensing and reimbursement standards and 3. technologies that have evolved until smartphones become ubiquitous, making services such as health care more quickly delivered to consumers.
The rising elderly and medically disadvantaged populations (particularly in rural areas)
The Growing Cases of Chronic Diseases and Telehealth & Telemedicine's Cost-Benefits
Lack Physicians are few.
Telecommunications has progressed.
Growing Public Awareness and Government Support
Region-by-Region Regulatory Differences
In the field of telemedicine and telehealth, there is a lot of fraud going on.
Social Media Applicability
High Value in the Fight Against Infectious Diseases and Epidemics
Implementation of Blockchain
Artificial Intelligence and Analytics
Unable to Ensure Hygiene and Cleanliness
Healthcare Affordability and Behavioral Barriers
IMPACT OF COVID-19
The COVID-19 epidemic has had a devastating global impact on human health and a major economic impact in many lands.
The COVID-19 epidemic, on the other hand, presents significant opportunities in the telehealth and telemedicine markets, given that community reduction is the only available solution that can reduce exposure.
The epidemic, however, offers a host of opportunities for telehealth solutions, given its potential to reduce exposure. Telemedicine also helps keep healthcare providers safe. Telemedicine technology, with its growing effects throughout the continuity of health care delivery, serves as an important asset in the industry. Because of its few advantages, especially in general care and situations where services do not require direct contact with the patient, telemedicine can be a powerful way to monitor and communicate to ensure the proper use of provider services. In addition, the corresponding decline in resource use due to the low demand for personal protective equipment may result in significant savings when considered on a national, continental, or global scale. However, with the rapid increase in usage, mobile companies may face baggage management challenges and may face technical problems and IT crashes, which may require complex mobility solutions. Therefore, telephone companies also have a good opportunity to understand and evaluate these challenges and to deal with such situations.
The telehealth market and telemedicine are divided into software and services, as well as hardware components. By 2021, the software and services segment had the largest share in the telehealth and telemedicine markets. A large part of this phase is due to the increasing adoption of telehealth and telemedicine worldwide. Telehealth software and services have experienced significant growth due to the COVID-19 epidemic, which has resulted in hospitals facing severe shortages of beds and facilities, as well as social isolation practices.
The telehealth and telemedicine markets are divided into teleradiology, teleconsultation telelCU, telestroke, telepsychiatry, teledermatology, and other applications. In practice, the teleradiology component had the largest share in the telehealth and telemedicine markets by 2021. Factors such as the proliferation of thought processes, the increase in the acquisition of teleradiology work by health care providers, and the simplification and control of teleradiology processes are some of the major factors. factors that drive the growth of this phase. In addition, the COVID-19 epidemic has supported the use of teleradiology, as radiologists seek to reduce patient exposure while ensuring adequate mobility.
By End User:
The telehealth and telemedicine market is divided into providers, payers, patients and other end users. The supplier segment had the largest share in the global telehealth and telemedicine market, by end users, by 2021. Factors contributing to much of this phase include increased acceptance of remote monitoring in chronically ill and elderly patients, health improvements. monitoring items, an increase in the number of tele-specialty services provided by providers, and the significant impact of the COVID-19 epidemic, which has resulted in hospitals facing severe shortages of beds and equipment.
Some of the major key players are as follows: Asahi Kasei Corporation, Medtronic, Koninklijke Philips N.V., Siemens Healthineers, Cerner Corporation, Cisco Systems, GE Healthcare, Teladoc Health, American Well, and other players.
Software & services
By Mode of Delivery
By End User
North America had the largest share of the health market in 2021. The region's major allocation can be attributed to factors such as the growing need to reduce COVID-19 cases, the government's mandate to expand health facilities, and the growing focus on quality improvement. of care provided to COVID-19 patients. Increased burden on hospitals to manage patient data due to the growing burden of patients makes it necessary for hospitals and physicians to adopt a variety of telephone solutions. However, the Asia Pacific market is expected to grow at a much higher rate during the forecast period, due to the spread of chronic diseases and overcrowding.
Rest of Europe
Rest of Asia-Pacific
The Middle East & Africa
Rest of Middle East & Africa
Rest of Latin America
|Market Size in 2021||US$ 68.8 Billion|
|Market Size by 2028||US$ 360.5 Billion|
|CAGR||CAGR of 26.7% From 2022 to 2028|
|Report Scope & Coverage||Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook|
|Key Segments||• By Component (Software & services, Hardware)
• By Mode of Delivery (Cloud-based, On-premise)
• By Application (Teleconsultation, TeleICU, Telestroke, Teleradiology, Telepsychiatry, Teledermatology, Other)
• By End User (Providers, Payers, Patients, Other)
|Regional Analysis/Coverage||North America (USA, Canada, Mexico), Europe
(Germany, UK, France, Italy, Spain, Netherlands,
Rest of Europe), Asia-Pacific (Japan, South Korea,
China, India, Australia, Rest of Asia-Pacific), The
Middle East & Africa (Israel, UAE, South Africa,
Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America)
|Company Profiles||Asahi Kasei Corporation, Medtronic, Koninklijke Philips N.V., Siemens Healthineers, Cerner Corporation, Cisco Systems, GE Healthcare, Teladoc Health, American Well, and other players.|
|DRIVERS||• The rising elderly and medically disadvantaged populations (particularly in rural areas)
• The Growing Cases of Chronic Diseases and Telehealth & Telemedicine's Cost-Benefits
• Lack Physicians are few.
|RESTRAINTS||• Region-by-Region Regulatory Differences
• In the field of telemedicine and telehealth, there is a lot of fraud going on.
• Social Media Applicability
Frequently Asked Questions (FAQ) :
Software and services segment had the largest share in the telehealth and telemedicine markets.
North America had the largest share of the health market.
Telehealth and Telemedicine Market is divided into four segments and they are By Component, By Mode of Delivery, By Application, By End User
Region-by-Region Regulatory Differences, In the field of telemedicine and telehealth, there is a lot of fraud going on are the restraints of Telehealth and Telemedicine Market
Telehealth and Telemedicine market is expected grow at a CAGR of 26.7% over the forecast period 2022-2028.
Table of Contents
1.1 Market Definition
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
4. Impact Analysis
4.1 COVID 19 Impact Analysis
4.2 Impact of Ukraine ware
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Telehealth and Telemedicine Market Segmentation, By Component
8.1 Software & services
9. Telehealth and Telemedicine Market Segmentation, By Mode of Delivery
10. Telehealth and Telemedicine Market Segmentation, By Application
11. Telehealth and Telemedicine Market Segmentation, By End User
12. Regional Analysis
12.2 North America
12.3.6 The Netherlands
12.3.7 Rest of Europe
12.4.2 South Korea
12.4.6 Rest of Asia-Pacific
12.5 The Middle East & Africa
12.5.3 South Africa
12.6 Latin America
12.6.3 Rest of Latin America
13 Company Profiles
13.1 Asahi Kasei Corporation
13.1.2 Products/ Services Offered
13.1.3 SWOT Analysis
13.1.4 The SNS view
13.3 Koninklijke Philips N.V.
13.4 Siemens Healthineers
13.5 Cerner Corporation
13.6 Cisco Systems
13.7 GE Healthcare
13.8 Teladoc Health
13.9 American Well
14 Competitive Landscape
14.1 Competitive Benchmark
14.2 Market Share analysis
14.3 Recent Developments
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.